The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for R Nubbemeyer


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of IRAK4 Inhibitors EBI
Bayer
Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women.EBI
Bayer
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor EBI
Bayer
Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo.EBI
Bayer
CHROMEN-2-ONE MODULATORS OF POLRMTBDB
Pretzel Therapeutics
HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORSBDB
Chiesi Farmaceutici
Spirocycle compounds and methods of making and using sameBDB
Lundbeck La Jolla Research Center
Kinase inhibitorsBDB
Topivert Pharma
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their useBDB
Merck Sharp & Dohme
Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.BDB
Shaoyang University